MEI Pharma, Inc.
Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acr- ylamide and uses thereof
Last updated:
Abstract:
Crystalline polymorph forms of 3-[2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acry- lamide are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of diseases and conditions are also presented.
Status:
Grant
Type:
Utility
Filling date:
1 May 2017
Issue date:
21 Apr 2020